How to wean off 60mg of Cymbalta (duloxetine)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Wean Off 60mg of Cymbalta (Duloxetine)

Taper duloxetine gradually over at least 2-4 weeks by reducing the dose in small decrements, monitoring closely for withdrawal symptoms at each step, and never use alternate-day dosing as this significantly increases withdrawal risk. 1

Tapering Strategy

The recommended approach is to reduce duloxetine by small increments (typically 10-20% of the current dose) every 1-2 weeks, allowing adequate time at each dose level to assess for withdrawal symptoms before proceeding. 1

Specific Tapering Schedule from 60mg

  • Start by reducing from 60mg to 30mg daily for 1-2 weeks, as this represents the available capsule strength and allows monitoring for withdrawal symptoms 1
  • After tolerating 30mg for 1-2 weeks, consider further reduction to 20mg daily (if available) or opening capsules to create smaller doses, maintaining each reduction for at least 1-2 weeks 1
  • The total taper duration should be at least 2-4 weeks minimum, though slower tapers over 4-8 weeks may be better tolerated, especially if you've been on duloxetine for many months or years 1

Critical Pitfall to Avoid

Never use alternate-day dosing (taking 60mg every other day) as a tapering strategy. Recent pharmacokinetic modeling demonstrates that alternate-day dosing causes severe fluctuations in receptor occupancy that dramatically increase withdrawal symptom risk, even at doses well below the therapeutic range 2. This approach, while sometimes recommended by clinicians, is not supported by evidence and will likely cause significant withdrawal effects 2.

Monitoring for Withdrawal Symptoms

Common duloxetine withdrawal symptoms include nausea, dizziness, headache, irritability, insomnia, sensory disturbances ("brain zaps"), anxiety, and fatigue. 3, 4

  • Monitor yourself daily during the taper, particularly in the first 3-5 days after each dose reduction when withdrawal symptoms are most likely to emerge 1
  • If withdrawal symptoms occur, return to the previous dose that was tolerated, stabilize for an additional 1-2 weeks, then attempt a smaller reduction (e.g., 5-10% instead of 20%) 1

When to Slow the Taper

If you experience significant withdrawal symptoms at any step:

  • Return immediately to the last tolerated dose 1
  • Stabilize at that dose for at least 1-2 additional weeks 1
  • Make smaller dose reductions going forward (5-10% decrements rather than larger jumps) 1

Duration Considerations

The need for tapering is particularly important if you've been on duloxetine for longer than 3 weeks, as discontinuation symptoms are common after this duration 1. The longer you've been on the medication, the slower your taper should generally be.

Special Circumstances

If discontinuing due to adverse effects rather than treatment completion, a more rapid taper may be necessary but requires closer monitoring and medical supervision. 1 In such cases, the reason for discontinuation should guide the tapering schedule, balancing the urgency of stopping against withdrawal risk 1.

Work with your prescribing physician throughout this process, as they can provide appropriate dose formulations, monitor for complications, and adjust the taper schedule based on your individual response 1.

References

Guideline

Duloxetine Scheduling and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety and adverse event profile of duloxetine.

Expert opinion on drug safety, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.